Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Inventory Average (2016 - 2025)

Historic Inventory Average for Ocular Therapeutix (OCUL) over the last 12 years, with Q4 2025 value amounting to $3.5 million.

  • Ocular Therapeutix's Inventory Average rose 2951.33% to $3.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.5 million, marking a year-over-year increase of 2951.33%. This contributed to the annual value of $3.3 million for FY2025, which is 2355.47% up from last year.
  • According to the latest figures from Q4 2025, Ocular Therapeutix's Inventory Average is $3.5 million, which was up 2951.33% from $3.3 million recorded in Q3 2025.
  • In the past 5 years, Ocular Therapeutix's Inventory Average registered a high of $3.5 million during Q4 2025, and its lowest value of $1.1 million during Q2 2021.
  • For the 5-year period, Ocular Therapeutix's Inventory Average averaged around $2.1 million, with its median value being $2.2 million (2023).
  • Per our database at Business Quant, Ocular Therapeutix's Inventory Average surged by 280.59% in 2021 and then soared by 6257.67% in 2023.
  • Over the past 5 years, Ocular Therapeutix's Inventory Average (Quarter) stood at $1.2 million in 2021, then skyrocketed by 42.35% to $1.8 million in 2022, then grew by 29.64% to $2.3 million in 2023, then increased by 19.36% to $2.7 million in 2024, then increased by 29.51% to $3.5 million in 2025.
  • Its Inventory Average stands at $3.5 million for Q4 2025, versus $3.3 million for Q3 2025 and $3.2 million for Q2 2025.